97 related articles for article (PubMed ID: 15557368)
1. Functional interplay between the macrophage scavenger receptor class B type I and pitavastatin (NK-104).
Han J; Parsons M; Zhou X; Nicholson AC; Gotto AM; Hajjar DP
Circulation; 2004 Nov; 110(22):3472-9. PubMed ID: 15557368
[TBL] [Abstract][Full Text] [Related]
2. Experimental glomerulopathy alters renal cortical cholesterol, SR-B1, ABCA1, and HMG CoA reductase expression.
Johnson AC; Yabu JM; Hanson S; Shah VO; Zager RA
Am J Pathol; 2003 Jan; 162(1):283-91. PubMed ID: 12507911
[TBL] [Abstract][Full Text] [Related]
3. Targeting the SR-B1 Receptor as a Gateway for Cancer Therapy and Imaging.
Mooberry LK; Sabnis NA; Panchoo M; Nagarajan B; Lacko AG
Front Pharmacol; 2016; 7():466. PubMed ID: 28018216
[TBL] [Abstract][Full Text] [Related]
4. Ligand-dependent interactions between SR-B1 and S1PR1 in macrophages and atherosclerotic plaques.
Bassila C; Kluck GEG; Thyagarajan N; Chathely KM; Gonzalez L; Trigatti BL
J Lipid Res; 2024 Apr; 65(5):100541. PubMed ID: 38583587
[TBL] [Abstract][Full Text] [Related]
5. Pitavastatin attenuates atherosclerosis by suppressing NF-κB signaling in a high-cholesterol diet plus balloon catheter injury rabbit model.
Long M; Ke X; Zhu H; Liu G; Wu J; Liao X; Du Z
Int J Clin Exp Pathol; 2018; 11(1):351-358. PubMed ID: 31938118
[TBL] [Abstract][Full Text] [Related]
6. Effect of
Rani MR; Azemi AK; Bakar K; Abu-Bakar L; Muhammad TST; Ismail N
Nat Prod Res; 2024 Mar; ():1-8. PubMed ID: 38486409
[TBL] [Abstract][Full Text] [Related]
7. Scavenger Receptor Class B type 1 (SR-B1) and the modifiable risk factors of stroke.
Lenahan C; Huang L; Travis ZD; Zhang JH
Chin Neurosurg J; 2019; 5():30. PubMed ID: 32922929
[TBL] [Abstract][Full Text] [Related]
8. Encapsulation of LXR ligand by D-Nap-GFFY hydrogel enhances anti-tumorigenic actions of LXR and removes LXR-induced lipogenesis.
Feng K; Ma C; Liu Y; Yang X; Yang Z; Chen Y; Xu T; Yang C; Zhang S; Li Q; Wei Z; Zhao D; Zeng P; Han J; Gao J; Chen Y; Duan Y
Theranostics; 2021; 11(6):2634-2654. PubMed ID: 33456564
[No Abstract] [Full Text] [Related]
9. Scavenger Receptors as Biomarkers and Therapeutic Targets in Cardiovascular Disease.
Cuthbert GA; Shaik F; Harrison MA; Ponnambalam S; Homer-Vanniasinkam S
Cells; 2020 Nov; 9(11):. PubMed ID: 33182772
[TBL] [Abstract][Full Text] [Related]
10. TRIM59 expression is regulated by Sp1 and Nrf1 in LPS-activated macrophages through JNK signaling pathway.
An Y; Ni Y; Xu Z; Shi S; He J; Liu Y; Deng KY; Fu M; Jiang M; Xin HB
Cell Signal; 2020 Mar; 67():109522. PubMed ID: 31883458
[TBL] [Abstract][Full Text] [Related]
11. Low scavenger receptor class B type I expression is associated with gastric adenocarcinoma tumor aggressiveness.
Wang X; Wu C; Yuan B; Wang D; Liu H; Feng H; Sun S
Oncol Lett; 2018 Apr; 15(4):4604-4610. PubMed ID: 29541232
[TBL] [Abstract][Full Text] [Related]
12. Pitavastatin Differentially Modulates MicroRNA-Associated Cholesterol Transport Proteins in Macrophages.
Zhang H; Lamon BD; Moran G; Sun T; Gotto AM; Hajjar DP
PLoS One; 2016; 11(7):e0159130. PubMed ID: 27415822
[TBL] [Abstract][Full Text] [Related]
13. High scavenger receptor class B type I expression is related to tumor aggressiveness and poor prognosis in breast cancer.
Yuan B; Wu C; Wang X; Wang D; Liu H; Guo L; Li XA; Han J; Feng H
Tumour Biol; 2016 Mar; 37(3):3581-8. PubMed ID: 26456958
[TBL] [Abstract][Full Text] [Related]
14. Augmented reduction of islet β-cell mass in Goto-Kakizaki rats fed high-fat diet and its suppression by pitavastatin treatment.
Mizukami H; Inaba W; Takahashi K; Inoue K; Sawanobori K; Yagihashi S
J Diabetes Investig; 2012 Jun; 3(3):235-44. PubMed ID: 24843571
[TBL] [Abstract][Full Text] [Related]
15. Endothelial Lipase Plasma Levels are Increased in Patients With Significant Carotid Artery Stenosis and History of Neurological Impairment.
Riederer M; Trbušić M; Degoricija V; Frank S
J Clin Med Res; 2012 Feb; 4(1):49-51. PubMed ID: 22383927
[TBL] [Abstract][Full Text] [Related]
16. Pleiotropic effects of pitavastatin.
Davignon J
Br J Clin Pharmacol; 2012 Apr; 73(4):518-35. PubMed ID: 22053916
[TBL] [Abstract][Full Text] [Related]
17. Increased expression of endothelial lipase in symptomatic and unstable carotid plaques.
Trbušić M; Riederer M; Vučić M; Lovričević I; Krušlin B; Gauster M; Mohrenz S; Berghold A; Tiran B; Degoricija V; Frank S
J Neurol; 2012 Mar; 259(3):448-56. PubMed ID: 21842303
[TBL] [Abstract][Full Text] [Related]
18. Scavenger receptor class B type I (SR-BI) regulates perivascular macrophages and modifies amyloid pathology in an Alzheimer mouse model.
Thanopoulou K; Fragkouli A; Stylianopoulou F; Georgopoulos S
Proc Natl Acad Sci U S A; 2010 Nov; 107(48):20816-21. PubMed ID: 21076037
[TBL] [Abstract][Full Text] [Related]
19. Open-label, ascending dose, prospective cohort study evaluating the antiviral efficacy of Rosuvastatin therapy in serum and lipid fractions in patients with chronic hepatitis C.
Patel K; Jhaveri R; George J; Qiang G; Kenedi C; Brown K; Cates C; Zekry A; Tillmann HL; Elliott L; Kilaru R; Albrecht J; Conrad A; McHutchison JG
J Viral Hepat; 2011 May; 18(5):331-7. PubMed ID: 20367801
[TBL] [Abstract][Full Text] [Related]
20. Pitavastatin suppresses mitogen activated protein kinase-mediated Erg-1 induction in human vascular smooth muscle cells.
Lamon BD; Summers BD; Gotto AM; Hajjar DP
Eur J Pharmacol; 2009 Mar; 606(1-3):72-6. PubMed ID: 19374880
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
